OEM News, People

Dentsply Sirona Hires Globus CEO Daniel Scavilla as Chief Exec

He succeeds Simon Campion, who is leaving the company on July 31.

Daniel Scavilla. Photo: Dentsply Sirona.

Dentsply Sirona announced that Daniel Scavilla has been named president and CEO, effective August 1. He succeeds Simon Campion, who is leaving the company on July 31.

Scavilla was most recently president and CEO of Globus Medical, where he led the acquisition of NuVasive and oversaw the two companies’ integration to create the second largest spine technology company in the world. He also served in the roles of CFO and executive VP, chief commercial officer, as well as president of Trauma.

Before joining Globus, he spent 28 years in financial and operational leadership roles at Johnson & Johnson. He held the position of CFO, worldwide VP finance of Advanced Sterilization Products there as well.

Scavilla was appointed to the Dentsply Sirona board of directors in February 2025.

“Dan’s appointment as CEO underscores the Board’s strong and unwavering commitment to delivering enhanced value to shareholders and positioning Dentsply Sirona for future success,” said Dentsply Sirona chairman Gergory Lucier. “Dan is a seasoned healthcare veteran, and we’re confident that his three decades of executive leadership experience and disciplined focus on commercial growth, product innovation and financial and operational excellence make him well-suited to lead the Company into its next chapter. There is significant untapped opportunity across the dental market, and we believe that Dan is the right leader to help accelerate the Company’s business transformation, reposition Dentsply Sirona as an industry leader and deliver long-term value creation.”

“Dentsply Sirona is a company that I have admired for its trusted brands, and since joining the Board in February, I have gained an even deeper appreciation for the enormous potential of our business, people and products,” Scavilla said. “The Board and I are aligned in our belief that, while our ongoing transformation is yielding results, there is more we can do to drive improved commercial, operational and financial performance across the organization. As I step into the CEO role, I look forward to working with the team to continue the Company’s transformation and drive sustained profitable growth and enhance value for all stakeholders.”

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters